Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 33 of 102, showing 5 Applications out of 510 total, starting on record 161, ending on 165

# Protocol No Study Title Investigator(s) & Site(s)

161.

ECCT/22/03/10   Solidarity Trial Vaccines
    Solidarity Trial Vaccines: An international randomised trial of candidate vaccines against COVID-19   
Principal Investigator(s)
1. Ayallo, John Mark O, AYALLO
2. Prof KAWANGO AGOT AGOT
3. DR. LUCAS TINA OTIENO OTIENO
4. DR.MARICIANA ONONO ONONO
5. DR.JANET OYIEKO OYIEKO
6. DR.Fredrick Kipyego Sawe SAWE
7. DR. MICHAEL M MUTUA Mutua
8. Dr Joshua Kimani KIMANI
9. DR. IRENE A. MUGENYA MUGENYA
Site(s) in Kenya
1. SWOP (Nairobi City county)
2. K-IRDO –KISUMU (Kisumu county)
3. VIBRI- VICTORIA BIOMEDICAL RESEARCH INSTITUTE –KISUMU (Kisumu county)
4. KEMRI-CENTRE FOR MICROBIOLOGY RESEARCH (CMR) LUMUMBA –KISUMU (Kisumu county)
5. KEMRI –CENTRE FOR CLINICAL RESEARCH BUTERE(CCR) (Kakamega county)
6. Kenya Medical Research Institute/Walter Reed Project (KEMRI/WRP) (Kericho county)
7. UNIVERSITY OF NAIROBI- KAVI- KANGEMI (Nairobi City county)
8. UNIVERSITY OF NAIROBI- KAVI- KNH (Nairobi City county)
 
View

162.

ECCT/22/03/08   CVIA 092
    “ A Phase 3 Multicenter, Observer Blind, Randomized, Controlled Study to Evaluate Safety (Ages 6 Months to 45 Years) and Non-inferiority (Ages 9-12 Months) of Multi-dose and Single-dose Vial Formulations of EuTCV (Vi-CRM197 Typhoid Conjugate Vaccine) against Typbar TCV® and Lot-to-Lot Consistency of the Immune Response (Ages 9-12 Months) to Multi-dose Vial Formulation EuTCV in Healthy African Participants”.    
Principal Investigator(s)
1. Dr Lucy Koech Chepkurui Koech
Site(s) in Kenya
KEMRI/ KERICHO CRC
 
View

163.

ECCT/22/03/06   Sickle Cell Disease
    A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Characterize the Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients with Sickle Cell Disease   
Principal Investigator(s)
1. Janet Oyieko
2. Fredrick Chite Asirwa
3. Bernhards Ogutu
Site(s) in Kenya
1. Kombewa Clinical Research Centre (Kisumu county)
2. Victoria Biomedical Research institute (Kisumu county)
3. International Cancer Centre (Uasin Gishu county)
4. CREATES - Strathmore University Medical Centre (Nairobi City county)
 
View

164.

ECCT/22/03/03   HVTN 140/HPTN 101
        A phase 1 dose-escalation clinical trial to evaluate the safety, tolerability, and pharmacokinetics of PGDM1400LS alone and in combination with VRC07-523LS and PGT121.414.LS in healthy, HIV-uninfected adult participants_HVTN 140/HPTN 101       
Principal Investigator(s)
1. Josphat kosgei
Site(s) in Kenya
KEMRI WRP, KERICHO
 
View

165.

ECCT/22/03/04   VIBRI COVID-19-001/2021
    A Multi-Centre, Randomized, Double Blind, Phase 2b Trial to Evaluate the Safety and Immunogenicity of Janssen Ad26COVS1 and Novavax NVX-CoV2373 COVID-19 vaccines for Homologous and Heterologous Boosting in Adolescents and Adults Aged 12 to 64 Years with and without HIV infection in 3 African Countries (Kenya, Democratic Republic of Congo, and Rwanda).   
Principal Investigator(s)
1. Dr. Lucas Otieno Tina
Site(s) in Kenya
Victoria Biomedical Research Institute,
 
View